Search > Diabetes
My employer runs this trial

GLP-1 Receptor Agonists for Diabetes

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The Cleveland Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Participants will undergo evaluation with the Atmo capsule at two time points: at baseline before starting the GLP-1RA or dual agonist therapy and after the subject has been taking their GLP-1RA or dual agonist therapy for 3 months. The total expected time for patient participation is up to 4 months from the time they start their GLP-1RA or dual agonist therapy.

Are You a Good Fit for This Trial?

Inclusion Criteria

I am 18 years old or older.
I am starting or have stopped GLP-1RA or GLP-1RA/GIP therapy for type 2 diabetes or obesity.
Stable glucose control (HbA1c ≤ 9%) within 6 months of baseline visit
See 1 more

Exclusion Criteria

I have not used opiates, marijuana, or certain gut medications in the past month.
I have taken antibiotics in the last 2 weeks.
I am able to understand and give my own consent for treatment.
See 4 more

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Participants initiating GLP-1RA therapyExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Cleveland Clinic

Lead Sponsor

Trials
1,072
Recruited
1,377,000+

Atmo Biosciences Pty Ltd

Industry Sponsor

Trials
4
Recruited
480+

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.